Stavros S. Niarchos Associate Professor in Pediatric Cardiology
Associate Professor of Pediatrics
Associate Professor of Cell and Developmental Biology
Lyden, David C.
(212) 746-3941 (212) 746-8423
David Lyden, M.D., Ph.D. comes to the Weill Cornell Department of Pediatrics, Division of Hematology/Oncology from the Cell Biology Department at Memorial Sloan-Kettering, where he was also a member of the Pediatric Brain Tumor Team. He was one of the leaders of the research team at Sloan-Kettering that developed a strain of mouse that is immune to certain types of cancer, surviving injections of malignant cells that quickly raise lethal tumors in normal mice.
He was also a major contributor to the study that showed that bone marrow harbors the cells that are essential to building the lining of tumor blood vessels, a finding which may lead to more targeted treatment for cancer, including the use of antibodies to block the mobilization of bone marrow cells. Most recently he co-authored work demonstrating that bone-marrow-derived vascular stem cells contribute to angiogenesis and growth of certain tumors.
He is a member of the Professional Advisory Board of the Children's Brain Tumor Foundation (CBTF). In 2000, he received a Clinical Scientist Development Award from the Doris Duke Charitable Foundation.
(212) 746-3941 
(212) 746-8423
Back to Top